{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:04Z","timestamp":1790054344914,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2172-15-19","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T23:01:41Z","timestamp":1399762901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["IL-33 is negatively associated with the BMI and confers a protective lipid\/metabolic profile in non-diabetic but not diabetic subjects"],"prefix":"10.1186","volume":"15","author":[{"given":"Amal","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Al-Ghimlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Al-Hubail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Bennakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monira","family":"Al-Arouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Behbehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Dermime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,10]]},"reference":[{"issue":"7121","key":"577_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006, 444 (7121): 840-846. 10.1038\/nature05482.","journal-title":"Nature"},{"issue":"2","key":"577_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/ajkd.2003.50055","volume":"41","author":"AM O'Hare","year":"2003","unstructured":"O'Hare AM, Tawney K, Bacchetti P, Johansen KL: Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis. 2003, 41 (2): 447-454. 10.1053\/ajkd.2003.50055.","journal-title":"Am J Kidney Dis"},{"key":"577_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20050855","volume":"202","author":"B Knoeche","year":"2005","unstructured":"Knoeche B, Lohr J, Kahn E, Bluestone JA, Abbas AK: Sequential development of interleukin 2\u2013dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med. 2005, 202: 1375-1386. 10.1084\/jem.20050855.","journal-title":"J Exp Med"},{"issue":"3","key":"577_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jvs.2011.01.003","volume":"54","author":"D Vykoukal","year":"2011","unstructured":"Vykoukal D, Davies MG: Vascular biology of metabolic syndrome. J Vasc Surg. 2011, 54 (3): 819-831. 10.1016\/j.jvs.2011.01.003.","journal-title":"J Vasc Surg"},{"issue":"2","key":"577_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11 (2): 98-107. 10.1038\/nri2925.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"577_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/eurheartj\/ehi506","volume":"27","author":"NF Murphy","year":"2006","unstructured":"Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ: Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J. 2006, 27 (1): 96-106.","journal-title":"Eur Heart J"},{"issue":"6","key":"577_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","volume":"6","author":"VZ Rocha","year":"2009","unstructured":"Rocha VZ, Libby P: Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009, 6 (6): 399-409. 10.1038\/nrcardio.2009.55.","journal-title":"Nat Rev Cardiol"},{"key":"577_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011, 29: 415-445. 10.1146\/annurev-immunol-031210-101322.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"577_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ncprheum0674","volume":"3","author":"F Lago","year":"2007","unstructured":"Lago F, Dieguez C, Gomez-Reino J, Gualillo O: Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007, 3 (12): 716-724. 10.1038\/ncprheum0674.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4","key":"577_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000212758","volume":"55","author":"M Zeyda","year":"2009","unstructured":"Zeyda M, Stulnig TM: Obesity, inflammation, and insulin resistance\u2013a mini-review. Gerontology. 2009, 55 (4): 379-386. 10.1159\/000212758.","journal-title":"Gerontology"},{"issue":"2","key":"577_CR11","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","volume":"185","author":"JE McLaren","year":"2010","unstructured":"McLaren JE, Michael DR, Salter RC, Ashlin TG, Calder CJ, Miller AM, Liew FY, Ramji DP: IL-33 reduces macrophage foam cell formation. J Immunol. 2010, 185 (2): 1222-1229. 10.4049\/jimmunol.1000520.","journal-title":"J Immunol"},{"issue":"6801","key":"577_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ: Atherosclerosis. Nature. 2000, 407 (6801): 233-241. 10.1038\/35025203.","journal-title":"Nature"},{"issue":"1","key":"577_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","volume":"134","author":"J Andersson","year":"2010","unstructured":"Andersson J, Libby P, Hansson GK: Adaptive immunity and atherosclerosis. Clin Immunol. 2010, 134 (1): 33-46. 10.1016\/j.clim.2009.07.002.","journal-title":"Clin Immunol"},{"issue":"16","key":"577_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352 (16): 1685-1695. 10.1056\/NEJMra043430.","journal-title":"N Engl J Med"},{"issue":"5","key":"577_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005, 23 (5): 479-490. 10.1016\/j.immuni.2005.09.015.","journal-title":"Immunity"},{"issue":"2","key":"577_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pharmthera.2011.02.005","volume":"131","author":"AM Miller","year":"2011","unstructured":"Miller AM, Liew FY: The IL-33\/ST2 pathway\u2013A new therapeutic target in cardiovascular disease. Pharmacol Ther. 2011, 131 (2): 179-186. 10.1016\/j.pharmthera.2011.02.005.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"577_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP: IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA. 2007, 104 (1): 282-287. 10.1073\/pnas.0606854104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"577_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCRESAHA.110.218867","volume":"107","author":"AM Miller","year":"2010","unstructured":"Miller AM, Asquith DL, Hueber AJ, Anderson LA, Holmes WM, McKenzie AN, Xu D, Sattar N, McInnes IB, Liew FY: Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res. 2010, 107 (5): 650-658. 10.1161\/CIRCRESAHA.110.218867.","journal-title":"Circ Res"},{"issue":"12","key":"577_CR19","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/j.1365-2222.2008.03114.x","volume":"38","author":"M Sakashita","year":"2008","unstructured":"Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Fujieda S, Nakamura Y, Yasuda K, Nakanishi K, Tamari M: Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy. 2008, 38 (12): 1875-1881. 10.1111\/j.1365-2222.2008.03114.x.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"577_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew FY, Pitman NI, McInnes IB: Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010, 10 (2): 103-110. 10.1038\/nri2692.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"577_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","volume":"205","author":"AM Miller","year":"2008","unstructured":"Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, Baker AH, McInnes IB, Liew FY: IL-33 reduces the development of atherosclerosis. J Exp Med. 2008, 205 (2): 339-346. 10.1084\/jem.20071868.","journal-title":"J Exp Med"},{"issue":"6","key":"577_CR22","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007, 117 (6): 1538-1549. 10.1172\/JCI30634.","journal-title":"J Clin Invest"},{"issue":"9","key":"577_CR23","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","volume":"187","author":"HR Turnquist","year":"2011","unstructured":"Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW: IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol. 2011, 187 (9): 4598-4610. 10.4049\/jimmunol.1100519.","journal-title":"J Immunol"},{"issue":"1","key":"577_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.atherosclerosis.2012.07.011","volume":"224","author":"K Pawlak","year":"2012","unstructured":"Pawlak K, Mysliwiec M, Pawlak D: Oxidized LDL to autoantibodies against oxLDL ratio - The new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients. Atherosclerosis. 2012, 224 (1): 252-257. 10.1016\/j.atherosclerosis.2012.07.011.","journal-title":"Atherosclerosis"},{"issue":"5","key":"577_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ijo.2012.118","volume":"37","author":"M Zeyda","year":"2013","unstructured":"Zeyda M, Wernly B, Demyanets S, Kaun C, Hammerle M, Hantusch B, Schranz M, Neuhofer A, Itariu BK, Keck M, Prager G, Wojta J, Stulnig TM: Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond). 2013, 37 (5): 658-665. 10.1038\/ijo.2012.118.","journal-title":"Int J Obes (Lond)"},{"issue":"10","key":"577_CR26","doi-asserted-by":"publisher","first-page":"e47830","DOI":"10.1371\/journal.pone.0047830","volume":"7","author":"AM Miller","year":"2012","unstructured":"Miller AM, Purves D, McConnachie A, Asquith DL, Batty GD, Burns H, Cavanagh J, Ford I, McLean JS, Packard CJ, Shiels PG, Turner H, Velupillai YN, Deans KA, Welsh P, McInnes IB, Sattar N: Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?. PLoS One. 2012, 7 (10): e47830-10.1371\/journal.pone.0047830.","journal-title":"PLoS One"},{"issue":"1","key":"577_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2337\/dc07-1572","volume":"31","author":"TJ Hoerger","year":"2008","unstructured":"Hoerger TJ, Segel JE, Gregg EW, Saaddine JB: Is glycemic control improving in U.S. adults?. Diabetes Care. 2008, 31 (1): 81-86.","journal-title":"Diabetes Care"},{"key":"577_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2013.00071","volume":"4","author":"H Kwon","year":"2013","unstructured":"Kwon H, Pessin JE: Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013, 4: 71-","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-15-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:07:50Z","timestamp":1630555670000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-15-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-15-19","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,10]]},"assertion":[{"value":"9 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}